108 related articles for article (PubMed ID: 38785155)
21. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
22. ITGB1 enhances the Radioresistance of human Non-small Cell Lung Cancer Cells by modulating the DNA damage response and YAP1-induced Epithelial-mesenchymal Transition.
Li Y; Sun C; Tan Y; Zhang H; Li Y; Zou H
Int J Biol Sci; 2021; 17(2):635-650. PubMed ID: 33613118
[No Abstract] [Full Text] [Related]
23. WWC3 regulates the Wnt and Hippo pathways via Dishevelled proteins and large tumour suppressor 1, to suppress lung cancer invasion and metastasis.
Han Q; Lin X; Zhang X; Jiang G; Zhang Y; Miao Y; Rong X; Zheng X; Han Y; Han X; Wu J; Kremerskothen J; Wang E
J Pathol; 2017 Aug; 242(4):435-447. PubMed ID: 28543074
[TBL] [Abstract][Full Text] [Related]
24. Brain metastases in patients with oncogenic-driven non-small cell lung cancer: Pros and cons for early radiotherapy.
Lee J; Ahn MJ
Cancer Treat Rev; 2021 Nov; 100():102291. PubMed ID: 34587557
[TBL] [Abstract][Full Text] [Related]
25. Outcome of stereotactic radiosurgery for patients with non-small cell lung cancer metastatic to the brain.
Mariya Y; Sekizawa G; Matsuoka Y; Seki H; Sugawara T
J Radiat Res; 2010; 51(3):333-42. PubMed ID: 20383028
[TBL] [Abstract][Full Text] [Related]
26. CDK5 Activates Hippo Signaling to Confer Resistance to Radiation Therapy Via Upregulating TAZ in Lung Cancer.
Zeng Y; Liu Q; Wang Y; Tian C; Yang Q; Zhao Y; Liu L; Wu G; Xu S
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):758-769. PubMed ID: 32407930
[TBL] [Abstract][Full Text] [Related]
27. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
Hu C; Chang EL; Hassenbusch SJ; Allen PK; Woo SY; Mahajan A; Komaki R; Liao Z
Cancer; 2006 May; 106(9):1998-2004. PubMed ID: 16572401
[TBL] [Abstract][Full Text] [Related]
28. Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation.
Improta G; Zupa A; Fillmore H; Deng J; Aieta M; Musto P; Liotta LA; Broaddus W; Petricoin EF; Wulfkuhle JD
J Proteome Res; 2011 Jul; 10(7):3089-97. PubMed ID: 21574647
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.
You B; Yang YL; Xu Z; Dai Y; Liu S; Mao JH; Tetsu O; Li H; Jablons DM; You L
Oncotarget; 2015 Feb; 6(6):4357-68. PubMed ID: 25738359
[TBL] [Abstract][Full Text] [Related]
30. [Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report].
Leduc C; Antoni D; Quoix É; Noël G
Cancer Radiother; 2015 May; 19(3):192-7. PubMed ID: 25841992
[TBL] [Abstract][Full Text] [Related]
31. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z
Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723
[TBL] [Abstract][Full Text] [Related]
32. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
33. The novel FAT4 activator jujuboside A suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation.
Wang W; Huang Q; Chen Y; Huang Z; Huang Y; Wang Y; Qi X; Liu Z; Lu L
Pharmacol Res; 2021 Aug; 170():105723. PubMed ID: 34116210
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic radiosurgery for patients with nonsmall cell lung carcinoma metastatic to the brain.
Kim YS; Kondziolka D; Flickinger JC; Lunsford LD
Cancer; 1997 Dec; 80(11):2075-83. PubMed ID: 9392329
[TBL] [Abstract][Full Text] [Related]
35. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
[TBL] [Abstract][Full Text] [Related]
36. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
[TBL] [Abstract][Full Text] [Related]
37. SIRT6 through PI3K/Akt/mTOR signaling pathway to enhance radiosensitivity of non-Small cell lung cancer and inhibit tumor progression.
Xiong L; Tan B; Lei X; Zhang B; Li W; Liu D; Xia T
IUBMB Life; 2021 Sep; 73(9):1092-1102. PubMed ID: 34033225
[TBL] [Abstract][Full Text] [Related]
38. MiR-99a Enhances the Radiation Sensitivity of Non-Small Cell Lung Cancer by Targeting mTOR.
Yin H; Ma J; Chen L; Piao S; Zhang Y; Zhang S; Ma H; Li Y; Qu Y; Wang X; Xu Q
Cell Physiol Biochem; 2018; 46(2):471-481. PubMed ID: 29614485
[TBL] [Abstract][Full Text] [Related]
39. Stereotactic irradiation of non-small cell lung cancer brain metastases: evaluation of local and cerebral control in a large series.
Fessart E; Mouttet Audouard R; Le Tinier F; Coche-Dequeant B; Lacornerie T; Tresch E; Scherpereel A; Lartigau E; Mirabel X; Pasquier D
Sci Rep; 2020 Jul; 10(1):11201. PubMed ID: 32641798
[TBL] [Abstract][Full Text] [Related]
40. Metastasis-directed radiotherapy for non-small cell lung cancer failured under TKI: A case report and literature review.
Kahvecioglu A; Kilickap S; Hurmuz P
Cancer Radiother; 2023 Dec; 27(8):731-735. PubMed ID: 37827958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
